ENHARNEX
Live / Registered — Registered (as of 12 May 2020)
What this means for you
Registered since 12 May 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88632332
- Registration number
- 6052097
- Mark type
- Stylized text
- Filed
- 26 Sept 2019
- Published for opposition
- 25 Feb 2020
- Registered
- 12 May 2020
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of cancer and auto-immune diseases, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prosecution history
- 12 May 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 May 2020 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2020 — PUBLISHED FOR OPPOSITION
- 05 Feb 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Jan 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jan 2020 — ASSIGNED TO LIE